Apparent diffusion coefficient measurements in progressive supranuclear palsy

被引:0
|
作者
T. Ohshita
M. Oka
Y. Imon
S. Yamaguchi
Y. Mimori
S. Nakamura
机构
[1] Third Department of Internal Medicine,
[2] Hiroshima University School of Medicine,undefined
[3] 1-2-3 Kasumi,undefined
[4] Minami-ku,undefined
[5] Hiroshima 734-8551,undefined
[6] Japan e-mail: ohshitat@mcai.med. hiroshima-u.ac.jp Tel.: + 81-82-2 57-52 01 Fax: + 81-82-5 05-04 90,undefined
来源
Neuroradiology | 2000年 / 42卷
关键词
Key words Progressive supranuclear palsy; Magnetic resonance imaging; Diffusion-weighted imaging;
D O I
暂无
中图分类号
学科分类号
摘要
We measured the apparent diffusion coefficient (ADC), using diffusion-weighted imaging (DWI) and signal intensity on T2-weighted MRI in the cerebral white matter of patients with progressive supranuclear palsy (PSP) and age-matched normal subjects. In PSP, ADC in the prefrontal and precentral white matter was significantly higher than in controls. There was no significant difference in signal intensity on T2-weighted images. The ADC did correlate with signal intensity. The distribution of the elevation of ADC may be the consequence of underlying pathological changes, such as neurofibrillary tangles or glial fibrillary tangles in the cortex. Our findings suggest that ADC measurement might be useful for demonstrating subtle neuropathological changes.
引用
收藏
页码:643 / 647
页数:4
相关论文
共 50 条
  • [41] Progressive supranuclear palsy (PSP)
    Schwarz, J.
    Arnold, G.
    Csoti, I.
    Fogel, W.
    Oechsners, M.
    Urban, P.
    Walter, U.
    Storch, A.
    AKTUELLE NEUROLOGIE, 2007, 34 : S25 - S27
  • [42] The differentiation of progressive supranuclear palsy
    Cordato, Nicholas J.
    Halliday, Glenda M.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (05) : 385 - 388
  • [43] FAMILIAL PROGRESSIVE SUPRANUCLEAR PALSY
    BROWN, J
    LANTOS, P
    STRATTON, M
    ROQUES, P
    ROSSOR, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (05): : 473 - 476
  • [44] Progressive supranuclear palsy on Guam
    Yamazaki M.
    Makifuchi T.
    Chen K.-M.
    Mori O.
    Katayama Y.
    Takahashi H.
    Oyanagi K.
    Acta Neuropathologica, 2001, 102 (5) : 510 - 514
  • [45] Dysphagia in Progressive Supranuclear Palsy
    Heather M. Clark
    Julie A. G. Stierwalt
    Nirubol Tosakulwong
    Hugo Botha
    Farwa Ali
    Jennifer L. Whitwell
    Keith A. Josephs
    Dysphagia, 2020, 35 : 667 - 676
  • [46] PROGRESSIVE SUPRANUCLEAR PALSY - REPLY
    RAFAL, RD
    NEUROLOGY, 1982, 32 (08) : 918 - 919
  • [47] PNEUMOENCEPHALOGRAPHY OF PROGRESSIVE SUPRANUCLEAR PALSY
    BENTSON, JR
    KEESEY, JC
    RADIOLOGY, 1974, 113 (01) : 89 - 94
  • [48] Progressive Supranuclear Palsy: an Update
    Armstrong, Melissa J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (03)
  • [49] Zolpidem in progressive supranuclear palsy
    Mayr, BJ
    Bonelli, RN
    Niederwieser, G
    Költringer, P
    Reisecker, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (02) : 184 - 185
  • [50] Rapidly Progressive Supranuclear Palsy
    Armstrong, Melissa J.
    Castellani, Rudy J.
    Reich, Stephen G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (01): : 70 - 72